2022 Global Drug Bioavailability Enhancement Summit

October 5-6, 2022, Philadelphia Marriott Downtown, Philadelphia, PA

PROGRAM      REGISTER

2022 Global Drug Bioavailability Enhancement Summit

October 5-6, 2022, Philadelphia Marriott Downtown, Philadelphia, PA

PROGRAM      REGISTER

2022 Global Drug Bioavailability Enhancement Summit

October 5-6, 2022, Philadelphia Marriott Downtown, Philadelphia, PA

PROGRAM      REGISTER

2022 Global Drug Bioavailability Enhancement Summit

October 5-6, 2022, Philadelphia, PA | In-Person & Virtual Summit

2022 Global Drug Bioavailability Enhancement Summit

October 5-6, 2022, Philadelphia, PA | In-Person & Virtual Summit

2022 Global Drug Bioavailability Enhancement Summit

October 5-6, 2022, Philadelphia, PA | In-Person & Virtual Summit

Access today's LiveStream Below. Summit begins in:

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

After 2.5 years, we are finally back in-person (and virtual) in Philadelphia this October for industry’s leading drug product development Summit. Attend and connect with 160+ senior drug development innovators this October and uncover industry’s latest formulation and delivery technologies for improving drug product performance and bioavailability.

Uncover a multitude of new product development strategies, formulation approaches, delivery technologies in just 2 days. Likewise, access all session content for your team after the Summits are over via our on-demand portal. Benefit from 30+ expert sessions and panels including:

 

  • Targeted and Modified Delivery with Amneal
  • Model-Guided Formulation Design with Fractal Therapeutics
  • Nucleic Acid Delivery for Enabling MRNA with Eli Lilly
  • Long-Acting Injectables – Biopharmaceutics & Product Design with GlaxoSmithKline & Gilead
  • Rational Design of Oral Formulation with Merck
  • Spray Conjealing to Enhance Bioavailability with Otsuka
  • Predictive Power of SubCutaneous Injection Site Simulator with Merck
  • Advancing IVIVC of Subcutaneous Bioavailability with Amgen
  • MED 3D Printing for Oral Bioavailability with Triasek
  • Advances in Ocular Delivery with Genentech
  • Selection of Membrane-Permeable Peptides with Merck
  • and many more sessions and panels

As an added bonus for attendees, sponsors and exhibitors, this event is co-located with the 8th Controlled & Modified Drug Release Summit (LIVE and VIRTUAL also). You have access to BOTH events onsite!

Want to attend but need help to convince your boss?

Let us help by generating you a custom message for you to send to your boss. Email it, talk them through it in person, tweet it to them 280 characters at a time: up to you.

2022’s Speakers Include:

Pratik Saha, PhD

Pratik Saha, PhD

Director, Biopharmaceutics, Pharmaceutical Development

GlaxoSmithKline

Dipen Desai, PhD

Dipen Desai, PhD

Vice President, Complex Product Development

Amneal

Arijit Chakravarty, PhD

Arijit Chakravarty, PhD

Chief Executive Officer

Fractal Therapeutics

Manuel Sanchez-Felix, PhD

Manuel Sanchez-Felix, PhD

Senior Fellow, Novel Delivery Technologies

Novartis Institute for Biomedical Research

Ramesh Palaparthy, PhD

Ramesh Palaparthy, PhD

Executive Director, Clinical Pharmacology

Gilead Sciences

Wenzhan Yang, PhD

Wenzhan Yang, PhD

Senior Scientist, Pharmaceutical Development

AstraZeneca

Arul Joseph, PhD

Arul Joseph, PhD

Senior Director, CMC Pharmaceutical Dev

Otsuka Pharmaceuticals

Gillie Roth, PhD

Gillie Roth, PhD

Scientist, Preclinical & Translational PKPD

Genentech

Mikhail Murashov, PhD

Mikhail Murashov, PhD

Senior Scientist, Preclinical Development

Merck & Co.

Hamsini	Dhoolypala, PhD

Hamsini Dhoolypala, PhD

Senior Associate Scientist, Pharmacokinetics

Amgen

Debanjan Das, PhD

Debanjan Das, PhD

Senior Associate Director & Science Fellow

Bayer

Ingrid Liu, PhD

Ingrid Liu, PhD

Senior Scientist, Oral Formulation Sciences

Merck & Co.

Xiaoling Li, PhD

Xiaoling Li, PhD

Co-Founder & CEO

Triasek

Iriny Ekladious, PhD

Iriny Ekladious, PhD

Associate Principal Scientist, Sterile and Specialty Products

Merck & Co.

Santipharp Panmai, PhD

Santipharp Panmai, PhD

Vice President and Head of Early-phase Formulation Development

WuXi STA

Nitin Swarnakar, PhD

Nitin Swarnakar, PhD

North American Pharma Applications Manage

BASF

Interested to showcase or present your platform technology to 100’s of senior pharma drug product development attendees?

  • Precision medicine & healthcare delivery
  • Rationale formulation design for poorly soluble compounds
  • In-vivo – in-vitro correlation
  • Solution behavior of amorphous solid dispersions
  • Nanosuspension for improving the bioavailability
  • Early formulation screening in drug discovery
  • 3D printing for biopharmaceuticals
  • Enhancing patient adherence via drug delivery
  • Innovative strategies around drug / device combinations

30+

Industry-led Speakers

100's

of Senior Participants

12+

Networking Hours

16

Tech Exhibitors

2022 Sponsors & Exhibitors

Fluid Air
Absorption Systems
Gattefosse
Gattefosse

Download The Bioavailability Previous Attendee List

Partnering with the 2022 Summit will also help you:

  • Enhance commercial relationships with existing clients through platform interaction, meetings, and discussing the latest opportunities
  • Raise your brand awareness to a captive and engaging audience, which most-of-all encompasses decision-making criteria
  • Elevate your profile amongst industry peers and developing a contact base through 1-2-1 networking sessions
  • Generate direct new business opportunities from senior-level attendees with decision-making criteria currently sourcing drug product development solutions

Attendee Pricing

Super Early-Bird

Register before 23 Sept, 2022

Virtual Summit

$449

In-Person Summit

$1895

Early Bird

Register before 4 Oct, 2022

Virtual Summit

$549

In-Person Summit

$1950

Standard Pricing

Register Oct 4, 2022 Onwards

Virtual Summit

$599

In-Person Summit

$1995

Featured Posts

Prodrug Approach for Improving Bioavailability

Prodrug Approach for Improving Bioavailability

A prodrug is a medication or compound that metabolizes into a pharmacologically active drug after administration, offering opportunities to optimize the pharmaceutical property to improve bioavailability. Approximately 10% of all marketed drugs worldwide can be...

read more
Register

Ready To Join Us?

Pin It on Pinterest

Share This